ATE45348T1 - (r)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid. - Google Patents

(r)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid.

Info

Publication number
ATE45348T1
ATE45348T1 AT85870068T AT85870068T ATE45348T1 AT E45348 T1 ATE45348 T1 AT E45348T1 AT 85870068 T AT85870068 T AT 85870068T AT 85870068 T AT85870068 T AT 85870068T AT E45348 T1 ATE45348 T1 AT E45348T1
Authority
AT
Austria
Prior art keywords
radical
oxo
alpha
ethyl
pyrrolidineacetamide
Prior art date
Application number
AT85870068T
Other languages
English (en)
Inventor
Jean Gobert
Corneliu Giurgea
Jean-Pierre Geerts
Guy Bodson
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of ATE45348T1 publication Critical patent/ATE45348T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT85870068T 1984-05-15 1985-05-14 (r)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid. ATE45348T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848412358A GB8412358D0 (en) 1984-05-15 1984-05-15 Pharmaceutical composition
EP85870068A EP0165919B1 (de) 1984-05-15 1985-05-14 (R)-Alpha-ethyl-2-oxo-1-pyrrolidinacetamid

Publications (1)

Publication Number Publication Date
ATE45348T1 true ATE45348T1 (de) 1989-08-15

Family

ID=10560975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85870068T ATE45348T1 (de) 1984-05-15 1985-05-14 (r)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid.

Country Status (23)

Country Link
US (2) US4696942A (de)
EP (1) EP0165919B1 (de)
JP (1) JPS60255764A (de)
AT (1) ATE45348T1 (de)
AU (1) AU574175B2 (de)
BG (2) BG50272A3 (de)
CA (1) CA1237138A (de)
CY (1) CY1568A (de)
DE (1) DE3572168D1 (de)
DK (1) DK163500C (de)
ES (2) ES8703419A1 (de)
FI (1) FI80674C (de)
GB (1) GB8412358D0 (de)
GR (1) GR851156B (de)
HK (1) HK62692A (de)
IE (1) IE58393B1 (de)
IL (1) IL75180A (de)
NO (1) NO164535C (de)
PL (2) PL144345B1 (de)
PT (1) PT80461B (de)
SG (1) SG80190G (de)
SU (3) SU1417799A3 (de)
ZA (1) ZA853636B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
GB8827389D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
US6124473A (en) * 1998-05-08 2000-09-26 Ucb, S.A. Process for preparing (s)- and (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
AU2002224847A1 (en) * 2000-11-21 2002-06-03 U C B, S.A. N-alkylated gaba compounds, processes for their preparation and their use as medicaments
DE60204224T2 (de) * 2001-03-22 2006-02-02 Ucb S.A. Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen
IL160045A0 (en) * 2001-08-10 2004-06-20 Ucb Sa Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
ATE424384T1 (de) 2003-12-02 2009-03-15 Ucb Pharma Sa Imidazolderivate, verfahren zu deren herstellung und deren anwendungen
CA2488325C (en) * 2004-11-22 2010-08-24 Apotex Pharmachem Inc. Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
WO2006128693A2 (en) 2005-06-01 2006-12-07 Ucb Pharma, S.A. 2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system
WO2010044878A1 (en) 2008-10-16 2010-04-22 The Johns Hopkins University Methods and compositions for improving cognitive function
RS54595B1 (sr) 2009-10-23 2016-08-31 Ucb Biopharma Sprl. Derivati 2-okso-1-pirolidinil imidazotiadiazola
CA2789014C (en) * 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
JP5969003B2 (ja) 2011-04-18 2016-08-10 ユセベ ファルマ ソシエテ アノニム 2−オキソ−1−イミダゾリジニルイミダゾチアジアゾール誘導体
CN102633675A (zh) * 2012-04-10 2012-08-15 南京大学 一种dl-2-氨基丁酰胺制备方法
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
EP2968237A4 (de) 2013-03-15 2016-08-31 Univ Johns Hopkins Verfahren und zusammensetzungen zur verbesserung der kognitiven funktion
ES2881081T3 (es) 2013-03-15 2021-11-26 Agenebio Inc Procedimientos y composiciones para mejorar la función cognitiva
PH12019500127B1 (en) 2014-01-21 2022-05-04 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
SMT201900545T1 (it) 2014-01-21 2019-11-13 Janssen Pharmaceutica Nv Combinazioni comprendenti modulatori allosterici positivi o agonisti ortosterici del recettore glutammatergico metabotropico sottotipo 2 e loro utilizzo
CA2986598C (en) 2015-05-22 2023-09-26 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
EP3890833B1 (de) 2018-12-04 2023-06-07 Metys Pharmaceuticals AG Synergistische zusammensetzungen mit (r)-2-(2-oxopyrrolidin-1-yl)butanamid und (s)-2-(2-oxopyrrolidin-1-yl)butanamid in einem nicht-racemischen verhältnis
US11384050B1 (en) 2021-02-03 2022-07-12 Vitaworks Ip, Llc Method for preparing levetiracetam and intermediates thereof
US12528770B2 (en) 2023-06-12 2026-01-20 Suzhou Brighthope Pharmatech Co., Ltd. Process for the production of levetiracetam and intermediates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
GB1583871A (en) * 1976-10-19 1981-02-04 Ucb Sa Anti-aggregants
FR2418790A1 (fr) * 1978-03-02 1979-09-28 Philagro Sa Nouveaux derives de pyrrolidinone-2 et compositions herbicides les contenant
AU579863B2 (en) * 1984-05-16 1988-12-15 Williams, David Andrew A parking control apparatus

Also Published As

Publication number Publication date
FI80674B (fi) 1990-03-30
JPS60255764A (ja) 1985-12-17
ZA853636B (en) 1985-12-24
ES8703419A1 (es) 1987-02-16
CY1568A (en) 1991-12-20
IE851192L (en) 1985-11-15
SU1428194A3 (ru) 1988-09-30
US4696942A (en) 1987-09-29
IL75180A0 (en) 1985-09-29
AU4252985A (en) 1985-11-21
EP0165919B1 (de) 1989-08-09
DE3572168D1 (de) 1989-09-14
NO164535B (no) 1990-07-09
DK212885D0 (da) 1985-05-14
BG60030B2 (bg) 1993-07-30
NO164535C (no) 1990-10-17
US4837224A (en) 1989-06-06
ES543125A0 (es) 1987-02-16
PL144345B1 (en) 1988-05-31
ES551366A0 (es) 1987-06-01
DK212885A (da) 1985-11-16
FI851876A0 (fi) 1985-05-13
IL75180A (en) 1988-05-31
SU1417799A3 (ru) 1988-08-15
PT80461A (fr) 1985-06-01
BG50272A3 (en) 1992-06-15
EP0165919A1 (de) 1985-12-27
GB8412358D0 (en) 1984-06-20
IE58393B1 (en) 1993-09-08
FI80674C (fi) 1990-07-10
DK163500B (da) 1992-03-09
DK163500C (da) 1992-07-27
PT80461B (pt) 1987-08-19
HK62692A (en) 1992-08-28
ES8706114A1 (es) 1987-06-01
PL257386A1 (en) 1986-10-07
PL253373A1 (en) 1986-05-06
CA1237138A (en) 1988-05-24
AU574175B2 (en) 1988-06-30
FI851876L (fi) 1985-11-16
SU1320207A1 (ru) 1987-06-30
PL147387B1 (en) 1989-05-31
NO851934L (no) 1985-11-18
GR851156B (de) 1986-11-25
SG80190G (en) 1990-11-23

Similar Documents

Publication Publication Date Title
DE3572168D1 (de) (r)-alpha-ethyl-2-oxo-1-pyrrolidinacetamide
DE3572348D1 (de) (s)-alpha-ethyl-2-oxo-1-pyrrolidinacetamide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee